Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-25-006500

Options or other derivatives

  • Chief Medical Officer acquired 53,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jones Mitchell Lawrence Chief Medical Officer 2025-02-11 Grant or award · Stock Option (Right to Buy) +29,000 29,000 D
Jones Mitchell Lawrence Chief Medical Officer 2025-02-11 Grant or award · Restricted Stock Units +24,000 24,000 D
Loading xslF345X05/ownership.xml…